Header Logo

Connection

TITILOPE FASIPE to Hemolysis

Back to Details
This is a "connection" page, showing publications TITILOPE FASIPE has written about Hemolysis.
TITILOPE FASIPE
Connection Strength
0.229
Hemolysis
  1. Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series. Pediatr Blood Cancer. 2024 Aug; 71(8):e31061.
    View in: PubMed
    Score: 0.229
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.